177 related articles for article (PubMed ID: 8760292)
1. Aberrant translational control of the c-myc gene in multiple myeloma.
Paulin FE; West MJ; Sullivan NF; Whitney RL; Lyne L; Willis AE
Oncogene; 1996 Aug; 13(3):505-13. PubMed ID: 8760292
[TBL] [Abstract][Full Text] [Related]
2. A mutation in the c-myc-IRES leads to enhanced internal ribosome entry in multiple myeloma: a novel mechanism of oncogene de-regulation.
Chappell SA; LeQuesne JP; Paulin FE; deSchoolmeester ML; Stoneley M; Soutar RL; Ralston SH; Helfrich MH; Willis AE
Oncogene; 2000 Sep; 19(38):4437-40. PubMed ID: 10980620
[TBL] [Abstract][Full Text] [Related]
3. Elevated c-myc messenger RNA in multiple myeloma cell lines.
Fourney R; Palmer M; Ng A; Dietrich K; Belch A; Paterson M; Brox L
Dis Markers; 1990; 8(3):117-24. PubMed ID: 1980237
[TBL] [Abstract][Full Text] [Related]
4. Investigation of aberrant translational control of c-myc in cell lines derived from patients with multiple myeloma.
Willis AE; Paulin FE; West MJ; Whitney RL
Curr Top Microbiol Immunol; 1997; 224():269-76. PubMed ID: 9308251
[TBL] [Abstract][Full Text] [Related]
5. Myc regulates VEGF production in B cells by stimulating initiation of VEGF mRNA translation.
Mezquita P; Parghi SS; Brandvold KA; Ruddell A
Oncogene; 2005 Jan; 24(5):889-901. PubMed ID: 15580293
[TBL] [Abstract][Full Text] [Related]
6. C-Myc 5' untranslated region contains an internal ribosome entry segment.
Stoneley M; Paulin FE; Le Quesne JP; Chappell SA; Willis AE
Oncogene; 1998 Jan; 16(3):423-8. PubMed ID: 9467968
[TBL] [Abstract][Full Text] [Related]
7. Translational upregulation of the c-myc oncogene in Bloom's syndrome cell lines.
West MJ; Sullivan NF; Willis AE
Oncogene; 1995 Dec; 11(12):2515-24. PubMed ID: 8545108
[TBL] [Abstract][Full Text] [Related]
8. [Suppression of c-myc expression by interference RNA in HepG2 hepatocellular carcinoma cells].
Xu Y; Wang YH; Gao JD; Ye J; Zhu HX; Xu NZ; Wang XY; Sun ZT
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):458-60. PubMed ID: 15555332
[TBL] [Abstract][Full Text] [Related]
9. Repression of alpha-fetoprotein gene expression under hypoxic conditions in human hepatoma cells: characterization of a negative hypoxia response element that mediates opposite effects of hypoxia inducible factor-1 and c-Myc.
Mazure NM; Chauvet C; Bois-Joyeux B; Bernard MA; Nacer-Chérif H; Danan JL
Cancer Res; 2002 Feb; 62(4):1158-65. PubMed ID: 11861398
[TBL] [Abstract][Full Text] [Related]
10. Loss of transcriptional attenuation in N-myc is associated with progression towards a more malignant phenotype.
Xu L; Meng Y; Wallen R; DePinho RA
Oncogene; 1995 Nov; 11(9):1865-72. PubMed ID: 7478616
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
Fan L; Iyer J; Zhu S; Frick KK; Wada RK; Eskenazi AE; Berg PE; Ikegaki N; Kennett RH; Frantz CN
Cancer Res; 2001 Feb; 61(3):1073-9. PubMed ID: 11221835
[TBL] [Abstract][Full Text] [Related]
12. Chlamydia trachomatis modulates expression of tumor suppressor gene caveolin-1 and oncogene C-myc in the transformation zone of non-neoplastic cervical tissue.
Schlott T; Eiffert H; Bohne W; Landgrebe J; Brunner E; Spielbauer B; Knight B
Gynecol Oncol; 2005 Sep; 98(3):409-19. PubMed ID: 16005053
[TBL] [Abstract][Full Text] [Related]
13. Selective expression of one c-myc allele in two human myeloma cell lines.
Kuehl WM; Brents LA; Chesi M; Bergsagel PL
Cancer Res; 1996 Oct; 56(19):4370-3. PubMed ID: 8813127
[TBL] [Abstract][Full Text] [Related]
14. FGF signaling inhibits the proliferation of human myeloma cells and reduces c-myc expression.
Firme L; Bush AB
BMC Cell Biol; 2003 Dec; 4():17. PubMed ID: 14656381
[TBL] [Abstract][Full Text] [Related]
15. Healthy mice with an altered c-myc gene: role of the 3' untranslated region revisited.
Langa F; Lafon I; Vandormael-Pournin S; Vidaud M; Babinet C; Morello D
Oncogene; 2001 Jul; 20(32):4344-53. PubMed ID: 11466615
[TBL] [Abstract][Full Text] [Related]
16. Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo.
Evans JR; Mitchell SA; Spriggs KA; Ostrowski J; Bomsztyk K; Ostarek D; Willis AE
Oncogene; 2003 Sep; 22(39):8012-20. PubMed ID: 12970749
[TBL] [Abstract][Full Text] [Related]
17. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
[TBL] [Abstract][Full Text] [Related]
18. [Synergism of c-myc and p16 in oral squamous cell carcinoma].
Liu NG; Shan CM; Wu SH; Lu ZH; Kang GY
Ai Zheng; 2004 Jun; 23(6):635-9. PubMed ID: 15191661
[TBL] [Abstract][Full Text] [Related]
19. Effects of tamoxifen and retinoic acid on cell growth and c-myc gene expression in human breast and cervical cancer cells.
Tsai LC; Hung MW; Yuan CC; Chao PL; Jiang SY; Chang GG; Chang TC
Anticancer Res; 1997; 17(6D):4557-62. PubMed ID: 9494568
[TBL] [Abstract][Full Text] [Related]
20. Amplification of the c-myc and the pvt-like region in human multiple myeloma.
Bakkus MH; Brakel-van Peer KM; Michiels JJ; van 't Veer MB; Benner R
Oncogene; 1990 Sep; 5(9):1359-64. PubMed ID: 2216459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
